For those who are either currently participating or interested in starting the precisionFDA and Georgetown ICBI Brain Cancer Predictive Modeling and Biomarker Discovery Challenge we have some exciting news! We have extended the challenge submission period, and a new incentive has been offered for the top three submissions! The extension details are as follows:
• Phase 1 submission period closes on February 5th
• Phase 2 data will be released February 7th
• Challenge submission period closes on February 14th
In addition to the challenge extension, we’ve added an incentive for the top three performing teams. These teams or individuals will be awarded a podium presentation at the 9th Annual Health Informatics and Data Science Symposium[/URL]. This conference is a great opportunity to meet and network with thought leaders in the fields of precision and molecular medicine, health data analytics, and bioinformatics.
To learn more about the challenge and participate visit https://go.usa.gov/xdbvW. Participants who have already submitted a Phase 1 model may use this additional time to improve upon their model and resubmit.
-
The field of epigenetics has traditionally concentrated more on DNA and how changes like methylation and phosphorylation of histones impact gene expression and regulation. However, our increased understanding of RNA modifications and their importance in cellular processes has led to a rise in epitranscriptomics research. “Epitranscriptomics brings together the concepts of epigenetics and gene expression,” explained Adrien Leger, PhD, Principal Research Scientist on Modified Bases...Yesterday, 07:01 AM -
Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...04-04-2024, 04:25 PM